EMA Decision P/0336/2024 Paediatric Investigation Plan for Retatrutide
Sold in boxes of 10 vials with a 100-vial order minimum you can mix and match across compounds
Borner, T., De Jonghe, B
The response begins within 10 min but is generally slower than cephalic phase events and peaks after an hour
Key weight loss results at 48 weeks by group: Response rates at 48 weeks (12 mg dose): 100% achieved greater than or equal to 5% weight loss 93% achieved greater than or equal to 10% weight loss 83% achieved greater than or equal to 15% weight loss The cardiometabolic improvements were also significant, with reductions in blood pressure, triglycerides, LDL cholesterol, HbA1c, fasting glucose, and fasting insulin across all dose groups
The provider can review appetite changes, nausea, constipation, hydration, protein intake, dose questions, prescription access, plateaus, and whether weight loss is moving too quickly or too slowly